Skip to main content

Table 1 Demographics and patients’ characteristics (n = 25 patients)

From: Long-term outcome in new onset refractory status epilepticus: a retrospective study

Age, in years (SD)

54 (17)

Female n (%)

17 (68)

Charlson Comorbidity Index [IQR]

1 [0–4]

mRS at admission to hospital [IQR]

3 [2–5]

STESS

3 [2–4]

SOFA

8 [5–9]

SAPS

48 [36–58]

Super-refractory SE, n (%)

24 (96)

Cause of NORSE identified, n (%)

8 (32)

MRI performed, n (%)

25 (100)

Lumbar puncture performed, n (%)

25 (100)

FDG-PET

13 (52)

Brain biopsy

5 (20)

Reasons for ICU admission

 

  Seizures, n (%)

13 (52)

  Coma, n (%)

7 (28)

  Confusion/Agitation, n (%)

3 (12)

  Others, n (%)

2 (8)

  1. SE Status epilepticus; mRS modified Rankin scale; STESS Status Epilepticus Severity Score; SOFA Sequential Organ Failure Assessment Score; SAPS Simplified Acute Physiology Score II; NORSE New onset refractory status epilepticus. MRI Magnetic resonance; FDG-PET 18-Fluorodeoxyglucose-positron emission tomography; ICU Intensive care unit. Data are present as counts/percentages, mean ± standard deviation (SD), or as median including the interquartile range (IQR), as appropriate